We also validated the presence of CD160+CD8+ T cells based on a publicly available human autopsy scRNA-seq dataset28, and the lung autopsy samples from COVID-19 patients demonstrated fewer CD160+CD8+ cells than controls (Fig. 3f). The gene discussed is CD160; the disease is COVID-19.